<?xml version="1.0"?>
<!DOCTYPE ArticleSet PUBLIC "-//NLM//DTD PubMed 2.0//EN" "http://www.ncbi.nlm.nih.gov/entrez/query/static/PubMed.dtd">
<ArticleSet>
  <Article>
    <Journal>
      <PublisherName>barw</PublisherName>
      <JournalTitle>Judi Clinical Journal</JournalTitle>
      <Issn>3105-4102</Issn>
      <Volume>1</Volume>
      <Issue>2</Issue>
      <PubDate PubStatus="epublish">
        <Year>2025</Year>
        <Month>11</Month>
        <Day>18</Day>
      </PubDate>
    </Journal>
    <ArticleTitle>Clinicopathological Profile of Malignant Tumors at a Tertiary Center in Iraq: A Five-Year Analysis</ArticleTitle>
    <FirstPage>89</FirstPage>
    <LastPage>98</LastPage>
    <ELocationID EIdType="doi">10.70955/JCJ.2025.12</ELocationID>
    <Language>eng</Language>
    <AuthorList>
      <Author>
        <FirstName>Fahmi H. </FirstName>
        <LastName>Kakamad</LastName>
        <Affiliation>College of Medicine, University of Sulaimani, Madam Mitterrand Street, Sulaymaniyah, Iraq</Affiliation>
        <Identifier Source="ORCID">0000-0002-2124-9580</Identifier>
      </Author>
      <Author>
        <FirstName>Berun A. </FirstName>
        <LastName>Abdalla</LastName>
        <Affiliation>Scientific Affairs Department, Smart Health Tower, Madam Mitterrand Street, Sulaymaniyah, Iraq</Affiliation>
      </Author>
      <Author>
        <FirstName>Dahat A. </FirstName>
        <LastName>Hussein</LastName>
        <Affiliation>Laboratory Department, Smart Health Tower, Madam Mitterrand Street, Sulaymaniyah, Iraq</Affiliation>
      </Author>
      <Author>
        <FirstName>Fakher </FirstName>
        <LastName>Abdullah</LastName>
        <Affiliation>Kscien Organization for Scientific Research (Middle East Office), Hamdi Street, Azadi Mall, Sulaymaniyah, Iraq.</Affiliation>
      </Author>
      <Author>
        <FirstName>Ayman M. </FirstName>
        <LastName>Mustafa</LastName>
        <Affiliation>Scientific Affairs  Department, Smart Health Tower, Madam Mitterrand Street, Sulaymaniyah, Iraq</Affiliation>
      </Author>
      <Author>
        <FirstName>Sabah J. </FirstName>
        <LastName>Hasan</LastName>
        <Affiliation>Scientific Affairs  Department, Smart Health Tower, Madam Mitterrand Street, Sulaymaniyah, Iraq</Affiliation>
      </Author>
      <Author>
        <FirstName>Mohammed S. </FirstName>
        <LastName>Ezzat</LastName>
        <Affiliation>Operation Theater Department, Smart Health Tower, Madam Mitterrand Street, Sulaymaniyah, Iraq</Affiliation>
      </Author>
      <Author>
        <FirstName>Harem S. </FirstName>
        <LastName>Amin</LastName>
        <Affiliation>Pharmacy Department, Smart Health Tower, Madam Mitterrand Street, Sulaymaniyah, Iraq</Affiliation>
      </Author>
      <Author>
        <FirstName>Lanya Q. </FirstName>
        <LastName>Rashid</LastName>
        <Affiliation>Operation Theater Department, Smart Health Tower, Madam Mitterrand Street, Sulaymaniyah, Iraq</Affiliation>
      </Author>
      <Author>
        <FirstName>Muhammad A. </FirstName>
        <LastName>Khdir</LastName>
        <Affiliation>Pharmacy Department, Smart Health Tower, Madam Mitterrand Street, Sulaymaniyah, Iraq</Affiliation>
      </Author>
      <Author>
        <FirstName>Danyar G. </FirstName>
        <LastName>HamaSaeed</LastName>
        <Affiliation>Pharmacy Department, Smart Health Tower, Madam Mitterrand Street, Sulaymaniyah, Iraq</Affiliation>
      </Author>
      <Author>
        <FirstName>Hussein H.</FirstName>
        <LastName> Rasul</LastName>
        <Affiliation>Pharmacy Department, Smart Health Tower, Madam Mitterrand Street, Sulaymaniyah, Iraq</Affiliation>
      </Author>
      <Author>
        <FirstName>Akam R. </FirstName>
        <LastName>Ahmed</LastName>
        <Affiliation>Operation Theater Department, Smart Health Tower, Madam Mitterrand Street, Sulaymaniyah, Iraq</Affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2025</Year>
        <Month>08</Month>
        <Day>18</Day>
      </PubDate>
    </History>
    <Abstract>Introduction: Cancer incidence and mortality are increasing worldwide, disproportionately affecting low- and middle-income countries due to limited healthcare access. This study aims to analyze the prevalence and clinicopathological characteristics of cancers diagnosed at a tertiary care center, offering crucial data to inform regional cancer control efforts.

Methods:&#xA0;This retrospective study was conducted at a single tertiary center, analyzing histopathological reports from January 2020 to January 2025. Data were collected from digital and physical archives by a trained team, including only confirmed malignant diagnoses. Variables extracted included patient demographics, cancer types, tumor characteristics, and procedure details. Data integrity was ensured through double-entry and expert review. Statistical analysis using SPSS 27.0 summarized categorical variables as frequencies, percentages and continuous variables as means or medians.

Results:&#xA0;A total of 9,375 cases were analyzed (median age 48 years), with females comprising 75.74% (7,101 cases). The age-standardized incidence rate was 82.20 per 100,000. Head and neck cancers accounted for 2,903 cases (30.97%), primarily thyroid (2,208 cases), followed by thoracic malignant tumors with 2,556 cases (27.26%). Invasive ductal carcinoma was most frequent cancer type (2,392 cases, 25.5%). Larger tumors correlated significantly with positive margins and lymph node involvement (p &lt; 0.05).

Conclusion:&#xA0;The study highlights a unique cancer profile, with younger age at diagnosis and higher rates of head, neck, and thyroid cancers. These findings underscore the need for targeted screening and prevention strategies adapted to regional healthcare systems.
</Abstract>
  </Article>
</ArticleSet>
